Q1 2019 Holdings
Filed 2019-04-05 | 9 holdings | $303.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $151.8M | 4,248,888 | 50.0% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $90.5M | 3,616,221 | 29.8% |
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $31.3M | 803,106 | 10.3% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $14.4M | 1,084,696 | 4.8% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $8.8M | 2,215,384 | 2.9% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $3.6M | 4,492,975 | 1.2% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $2.5M | 101,855 | 0.8% |
| Achaogen, Inc. | Common Stock | 004449104 | $584.6K | 1,281,152 | 0.2% |
| OpGen, Inc. | Common Stock | 68373L109 | $61.7K | 102,167 | 0.0% |